FDA green-lights Brainlab's TraumaCad Mobile app

The FDA green-lights Brainlab's mobile version of the TraumaCad surgical planning software for hip replacement procedures.

Brainlab said it won FDA clearance for a mobile version of its TraumaCad surgical planning software for hip replacement procedures.

The product, TraumaCad Mobile, will be marketed by Brainlab's Voyant Health unit. The application is compatible with Mac and PC web browsers plus iOS mobile devices.

Brainlab, Food & Drug Administration (FDA), Voyant Health

News Well, 510(k), Hips, Imaging, mHealth (Mobile Health), Orthopedics, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1DkH8lQ